B细胞与T细胞淋巴瘤双向风险显著增加
结果显示B细胞与T细胞淋巴瘤间整体双向风险近5倍增加,但风险因亚型差异显著,且风险在诊断后第一年最强并持续至5年以上。
要点
- B细胞与T细胞淋巴瘤间整体双向风险近5倍增加(SIR=4.7)。
- 霍奇金淋巴瘤与外周T细胞淋巴瘤非特指型间双向风险最高(SIR 27.5–31.6)。
- 风险在诊断后第一年最强,但5年以上仍持续升高。
核心结论
- B细胞与T细胞淋巴瘤之间存在显著双向增加的继发风险,且风险因淋巴瘤亚型不同而差异显著,支持淋巴瘤亚型间病因异质性。
主要发现
- B细胞淋巴瘤后发生T细胞淋巴瘤的SIR=4.7(95%CI 4.2-5.2),T细胞淋巴瘤后发生B细胞淋巴瘤的SIR=4.7(95%CI 4.1-5.2)。
- 霍奇金淋巴瘤后发生外周T细胞淋巴瘤非特指型的SIR=27.5,外周T细胞淋巴瘤非特指型后发生霍奇金淋巴瘤的SIR=31.6。
- 弥漫大B细胞淋巴瘤后发生血管免疫母细胞性T细胞淋巴瘤的SIR=9.7,血管免疫母细胞性T细胞淋巴瘤后发生弥漫大B细胞淋巴瘤的SIR=15.3。
- 上述风险在诊断后第一年最强,但在≥5年时仍持续升高。
- T细胞淋巴瘤与慢性淋巴细胞白血病/小淋巴细胞淋巴瘤及滤泡性淋巴瘤的所有关联SIR均<5。
临床怎么用
- 淋巴瘤幸存者应警惕第二原发淋巴瘤风险,尤其是霍奇金淋巴瘤与外周T细胞淋巴瘤非特指型、血管免疫母细胞性T细胞淋巴瘤与弥漫大B细胞淋巴瘤之间的双向关联。
- 第二原发淋巴瘤风险在诊断后第一年最高,但5年以上仍持续存在,提示长期随访的必要性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Lymphoma survivors have a significantly higher risk of developing second primary lymphoma than the general population; however, bidirectional risks of developing B- and T-cell lymphomas (BCLs and TCLs) specifically are less well understood. We used population-based cancer registry data to estimate the subtype-specific risks of second primary lymphoma among patients with first BCL (n = 288 478) or TCL (n = 23 747). We observed nearly fivefold increased bidirectional risk between BCL and TCL overall (TCL following BCL: standardized incidence ratio [SIR] = 4.7, 95% confidence interval [CI] = 4.2-5.2; BCL following TCL: SIR = 4.7, 95% CI = 4.1-5.2), but the risk varied substantially by lymphoma subtype. The highest SIRs were observed between Hodgkin lymphoma (HL) and peripheral T-cell lymphoma not otherwise specified (PTCL-NOS) (PTCL-NOS following HL: SIR = 27.5; HL following PTCL-NOS: SIR = 31.6). Strikingly elevated risks also were notable for angioimmunoblastic T-cell lymphoma (AITL) and diffuse large B-cell lymphoma (DLBCL) (AITL following DLBCL: SIR = 9.7; DLBCL following AITL: SIR = 15.3). These increased risks were strongest within the first year following diagnosis but remained persistently elevated even at ≥5 years. In contrast, SIRs were <5 for all associations of TCL with chronic lymphocytic leukemia/small lymphocytic lymphoma and follicular lymphoma. These patterns support etiologic heterogeneity among lymphoma subtypes and provide further insights into lymphomagenesis.
引用
- Chihara D, Dores GM, Flowers CR, et al. The bidirectional increased risk of B-cell lymphoma and T-cell lymphoma. Blood. 2021. PMID: 33822002. doi:10.1182/blood.2020010497
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。